Rallybio (RLYB) Competitors $0.34 +0.02 (+4.68%) Closing price 07/3/2025 02:50 PM EasternExtended Trading$0.34 0.00 (0.00%) As of 07/3/2025 04:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RLYB vs. ANVS, RNXT, AVTX, IPSC, KLTO, VTVT, BLUE, PRLD, APLT, and OSTXShould you be buying Rallybio stock or one of its competitors? The main competitors of Rallybio include Annovis Bio (ANVS), RenovoRx (RNXT), Avalo Therapeutics (AVTX), Century Therapeutics (IPSC), Klotho Neurosciences (KLTO), vTv Therapeutics (VTVT), bluebird bio (BLUE), Prelude Therapeutics (PRLD), Applied Therapeutics (APLT), and OS Therapies (OSTX). These companies are all part of the "pharmaceutical products" industry. Rallybio vs. Its Competitors Annovis Bio RenovoRx Avalo Therapeutics Century Therapeutics Klotho Neurosciences vTv Therapeutics bluebird bio Prelude Therapeutics Applied Therapeutics OS Therapies Rallybio (NASDAQ:RLYB) and Annovis Bio (NYSE:ANVS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends. Which has more risk and volatility, RLYB or ANVS? Rallybio has a beta of -1.17, meaning that its stock price is 217% less volatile than the S&P 500. Comparatively, Annovis Bio has a beta of 1.57, meaning that its stock price is 57% more volatile than the S&P 500. Which has higher earnings & valuation, RLYB or ANVS? Annovis Bio has lower revenue, but higher earnings than Rallybio. Annovis Bio is trading at a lower price-to-earnings ratio than Rallybio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRallybio$848K16.59-$57.78M-$1.09-0.31Annovis BioN/AN/A-$24.59M-$2.16-1.10 Do insiders & institutionals believe in RLYB or ANVS? 90.3% of Rallybio shares are held by institutional investors. Comparatively, 15.8% of Annovis Bio shares are held by institutional investors. 8.7% of Rallybio shares are held by insiders. Comparatively, 20.8% of Annovis Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor RLYB or ANVS? In the previous week, Rallybio's average media sentiment score of 0.00 equaled Annovis Bio'saverage media sentiment score. Company Overall Sentiment Rallybio Neutral Annovis Bio Neutral Is RLYB or ANVS more profitable? Annovis Bio has a net margin of 0.00% compared to Rallybio's net margin of -5,682.19%. Rallybio's return on equity of -72.31% beat Annovis Bio's return on equity.Company Net Margins Return on Equity Return on Assets Rallybio-5,682.19% -72.31% -64.78% Annovis Bio N/A -300.56%-193.50% Do analysts prefer RLYB or ANVS? Rallybio currently has a consensus price target of $10.00, indicating a potential upside of 2,858.58%. Annovis Bio has a consensus price target of $18.00, indicating a potential upside of 654.72%. Given Rallybio's higher possible upside, research analysts plainly believe Rallybio is more favorable than Annovis Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rallybio 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Annovis Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryRallybio and Annovis Bio tied by winning 7 of the 14 factors compared between the two stocks. Get Rallybio News Delivered to You Automatically Sign up to receive the latest news and ratings for RLYB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RLYB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RLYB vs. The Competition Export to ExcelMetricRallybioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.44M$2.91B$5.53B$8.95BDividend YieldN/A2.42%5.38%4.08%P/E Ratio-0.3121.5627.4020.24Price / Sales16.59281.35419.60118.25Price / CashN/A41.9536.6357.47Price / Book0.237.518.085.67Net Income-$57.78M-$55.05M$3.16B$248.47M7 Day Performance1.62%4.71%2.84%3.32%1 Month Performance-10.11%4.89%3.69%5.20%1 Year Performance-73.59%5.82%35.30%21.35% Rallybio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RLYBRallybio2.0293 of 5 stars$0.34+4.7%$10.00+2,858.6%-73.6%$13.44M$848K-0.3140ANVSAnnovis Bio1.6702 of 5 stars$2.64+1.5%$30.25+1,045.8%-70.5%$50.66MN/A-1.223RNXTRenovoRx2.9119 of 5 stars$1.41+2.2%$7.25+414.2%+20.5%$50.47M$40K-3.536Gap DownHigh Trading VolumeAVTXAvalo Therapeutics3.0694 of 5 stars$4.79+3.2%$30.00+526.3%-57.0%$50.24M$440K0.0040News CoverageIPSCCentury Therapeutics2.6992 of 5 stars$0.58-1.2%$4.20+630.4%-75.3%$50.14M$6.59M-1.98170KLTOKlotho NeurosciencesN/A$1.20-22.1%N/AN/A$50.04MN/A-3.33N/AVTVTvTv Therapeutics2.0576 of 5 stars$15.61+0.4%$35.50+127.5%-27.8%$49.66M$1.02M-5.189BLUEbluebird bio2.1245 of 5 stars$4.97flat$44.60+797.4%N/A$48.67M$103.95M-0.13520News CoveragePRLDPrelude Therapeutics3.4506 of 5 stars$0.84-2.4%$4.50+435.7%-77.6%$48.58M$7M-0.50120APLTApplied Therapeutics3.8192 of 5 stars$0.30-12.5%$6.10+1,933.3%-92.3%$48.55M$460K-0.7030Gap UpOSTXOS Therapies2.5056 of 5 stars$1.70-4.5%$18.00+958.8%N/A$47.77MN/A-1.98N/ANews CoverageGap Up Related Companies and Tools Related Companies Annovis Bio Alternatives RenovoRx Alternatives Avalo Therapeutics Alternatives Century Therapeutics Alternatives Klotho Neurosciences Alternatives vTv Therapeutics Alternatives bluebird bio Alternatives Prelude Therapeutics Alternatives Applied Therapeutics Alternatives OS Therapies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RLYB) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rallybio Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Rallybio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RLYB Stock Alerts